About this trial
Neonatal convulsions are seizures that occur during the first 28 days of a newborn's life. They are considered a medical emergency and often indicate an underlying problem in the brain, such as lack of oxygen at birth, infections, metabolic disturbances, or structural abnormalities. Many seizures in newborns are subtle and difficult to detect without careful clinical assessment.
This study aims to determine how often neonatal convulsions occur among newborns admitted to the Neonatal Intensive Care Unit (NICU) at Assiut University Children Hospital. It will describe how affected newborns present clinically, identify the main causes, and evaluate the early outcomes during hospitalization.
The study is designed as a prospective cohort study. Newborns aged 0-30 days who are diagnosed with neonatal convulsions will be enrolled and followed throughout their stay in the NICU. Each patient will undergo full clinical evaluation and standard laboratory and imaging investigations, including blood tests, neuroimaging, and other tests as clinically indicated.
The findings of this study will provide updated local data on the incidence, causes, and outcomes of neonatal convulsions in our region. This information may help improve early diagnosis, guide appropriate treatment, and enhance the quality of neonatal care.
Eligibility criteria
Qualifiers
Children aged between 0 to 30day.
Children diagnosed with neonatal seizures
All newborn fullterm,preterm.males and females with neonatal convulsions.
Disqualifiers
Children above age of 30 day and those with mimic condition as
jitteriness, benign neonatal sleep myoclonus, motor automatisms,
hyperekplexia, and Sandifer syndrome..
Trial design
Treatments tested in this trial
- Management of Neonatal Convulsions